Literature DB >> 1969878

Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.

J Sprent1, M Schaefer, R Korngold.   

Abstract

Detailed information was sought on the capacity of purified B6 L3T4+ cells to elicit lethal graft-versus-host disease (GVHD) in irradiated class II-different class I-identical (C57BL/6 (B6) x bm 12)F1 hosts. When B6 L3T4+ cells were transferred in small doses (10(5) to 10(6) together with donor bone marrow (BM) cells, the recipients all developed acute lethal GVHD and most of the mice died within 2 wk, probably from gut damage; this syndrome was conspicuous only in mice treated with very heavy irradiation, i.e., 1000 rad. In marked contrast to L3T4+ cells given in small doses, transfer of large doses of B6 L3T4+ cells to heavily irradiated (B6 x bm 12)F1 hosts paradoxically resulted in only limited mortality: most of the recipients survived for greater than 6 mo and manifested little or no evidence of ill health. It is suggested that the capacity of large doses of L3T4+ cells to protect mice against lethal GVHD is a reflection of T helper function: the cellular immunity provided by the donor L3T4+ cells enables the host to repel pathogens entering through damaged mucosal surfaces, with the result that GVHD becomes sublethal. The protective function of L3T4+ cells in the B6----bm 12 combination was only seen in hosts given donor BM. With transfer of donor L3T4+ cells plus host BM, even lightly irradiated recipients died rapidly from hemopoietic failure. Because this syndrome failed to occur in mice given a mixture of donor and host BM, it would appear that L3T4+ cells destroyed host lymphohemopoietic cells by direct cytotoxicity rather than via a bystander effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969878

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient.

Authors:  Ashley Munchel; Allen Chen; Heather Symons
Journal:  Clin Pediatr Emerg Med       Date:  2011-09

2.  CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.

Authors:  Hyo Jin Park; Dahye Byun; An Hi Lee; Ju Hyun Kim; Young Larn Ban; Masatake Araki; Kimi Araki; Ken-Ichi Yamamura; Inho Kim; Seong Hoe Park; Kyeong Cheon Jung
Journal:  Mol Cells       Date:  2012-02-15       Impact factor: 5.034

3.  Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.

Authors:  Brile Chung; Eric P Dudl; Dullei Min; Lora Barsky; Nancy Smiley; Kenneth I Weinberg
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

Review 4.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 5.  Mouse models of graft-versus-host disease: advances and limitations.

Authors:  Mark A Schroeder; John F DiPersio
Journal:  Dis Model Mech       Date:  2011-05       Impact factor: 5.758

6.  Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells.

Authors:  J Sprent; C D Surh; D Agus; M Hurd; S Sutton; W R Heath
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

Review 7.  Treatment of graft-versus-host disease with naturally occurring T regulatory cells.

Authors:  Piotr Trzonkowski; Anna Dukat-Mazurek; Maria Bieniaszewska; Natalia Marek-Trzonkowska; Anita Dobyszuk; Jolanta Juścińska; Magdalena Dutka; Jolanta Myśliwska; Andrzej Hellmann
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

Review 8.  The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.

Authors:  Margherita Boieri; Pranali Shah; Ralf Dressel; Marit Inngjerdingen
Journal:  Front Immunol       Date:  2016-08-30       Impact factor: 7.561

9.  Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation.

Authors:  Peter M Schmid; Abdellatif Bouazzaoui; Karin Schmid; Christoph Birner; Christian Schach; Lars S Maier; Ernst Holler; Dierk H Endemann
Journal:  Cell Transplant       Date:  2017-08       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.